A Comparative Pharmaco-Clinical Study of Palash and Chakramarda in the managenant of Dadru kustha

A Comparative Pharmaco-Clinical Study of Palash (Butea monosperma Lam.kuntze) and Chakramarda (Cassia tora Linn) in the managenant of Dadru kustha - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091275

Enrollment

Registered

2025-07-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Individuals aged between 21-50 years without any discrimination of gender, caste, and religion, Patients fulfilling the diagnostic criteria. Individuals having clinical sign and symptoms of Dadru roga according to Ayurvedic classics. Individuals who will give written consent for the study.

Exclusion criteria

Exclusion criteria: Pregnancy and Lactating mothers. Subject having skin disorder other than Dadru. Immunocompromised patient (HIV, T.B.,) other complicated disorder uncontrolled diabetes, skin cancer, psoriasis, malignant of skin diseases, Generalized eczema, hansen s disease, cellulitis and other autoimmune disease Patient who used to Immunosuppressive drugs.

Design outcomes

Primary

Measure	Time frame
the reduction or elimination of symptoms like itching (Kandu), redness (Raga), eruptions (Pidika), and elevated circular skin lesions (Utsanna Mandala). Successful treatment aims to alleviate these symptoms and prevent recurrence.Timepoint: 7 week	—

Secondary

Measure	Time frame
Complete Blood Count (CBC) RBSTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDrAjay kurmi

pt khushilal sharma ayurveda collage bhopal

Sharmavinod389@gmail.com9926379195

Outcome results